急诊科入院时筛查高钙血症患者时,总钙和电离钙(pH=7.4)测试相等:一项回顾性描述性研究

IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Journal of Endocrinology and Metabolism Pub Date : 2021-10-01 DOI:10.14740/jem757
Regitze Wittenberg, T. R. Larsen, L. Stilgren, S. Antonsen
{"title":"急诊科入院时筛查高钙血症患者时,总钙和电离钙(pH=7.4)测试相等:一项回顾性描述性研究","authors":"Regitze Wittenberg, T. R. Larsen, L. Stilgren, S. Antonsen","doi":"10.14740/jem757","DOIUrl":null,"url":null,"abstract":"Background: Ionized calcium (pH = 7.4) (CaI) is a laborious test compared to tests for total calcium (CaT). However, CaI is the biologically active part of calcium in the blood and is therefore often considered the most relevant measure of calcium status. In this study, CaI and CaT tests were compared by identifying clinically relevant hypercalcemia (HC) in unselected patients acutely admitted to an emergency department (ED). Methods: CaI and CaT were measured in all medical patients admitted to the ED at a single Danish Hospital (N = 13,400) between January 2018 and May 2019. The majority (97%) of the patients were admitted 1 - 3 times summing up to a total of 17,838 admissions. As limits for clinically relevant HC, 1.45 mmol/L for CaI and 2.77 mmol/L for CaT were used. Mismatches were defined as one test being equal to or above the limit while the other test was within or below its reference interval. In cases of mismatch, the medical record was reviewed. Results: Seventeen mismatches with CaI ? 1.45 mmol/L were observed in 16 patients, of whom eight were known with diseases with risk of HC. Five patients had HC with no clinical relevance, one had HC of unknown relevance, and only two patients were discovered as having a prior unknown calcium metabolic disease. Three mismatches were observed in admissions with CaT ? 2.77 mmol/L. Mismatches did in none of these cases have any clinical consequences. Conclusion: By using CaT as a screening method for HC instead of CaI, only two patients with prior unrecognized HC would have been missed and it did not result in a large number of patients with false HC. We therefore find that CaT is an acceptable test when screening for HC in the ED. J Endocrinol Metab. 2021;11(5):108-114 doi: https://doi.org/10.14740/jem757","PeriodicalId":15712,"journal":{"name":"Journal of Endocrinology and Metabolism","volume":" ","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Total Calcium and Ionized Calcium (pH = 7.4) Tests Are Equal When Screening Patients for Hypercalcemia at Admission in the Emergency Department: A Retrospective Descriptive Study\",\"authors\":\"Regitze Wittenberg, T. R. Larsen, L. Stilgren, S. Antonsen\",\"doi\":\"10.14740/jem757\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Ionized calcium (pH = 7.4) (CaI) is a laborious test compared to tests for total calcium (CaT). However, CaI is the biologically active part of calcium in the blood and is therefore often considered the most relevant measure of calcium status. In this study, CaI and CaT tests were compared by identifying clinically relevant hypercalcemia (HC) in unselected patients acutely admitted to an emergency department (ED). Methods: CaI and CaT were measured in all medical patients admitted to the ED at a single Danish Hospital (N = 13,400) between January 2018 and May 2019. The majority (97%) of the patients were admitted 1 - 3 times summing up to a total of 17,838 admissions. As limits for clinically relevant HC, 1.45 mmol/L for CaI and 2.77 mmol/L for CaT were used. Mismatches were defined as one test being equal to or above the limit while the other test was within or below its reference interval. In cases of mismatch, the medical record was reviewed. Results: Seventeen mismatches with CaI ? 1.45 mmol/L were observed in 16 patients, of whom eight were known with diseases with risk of HC. Five patients had HC with no clinical relevance, one had HC of unknown relevance, and only two patients were discovered as having a prior unknown calcium metabolic disease. Three mismatches were observed in admissions with CaT ? 2.77 mmol/L. Mismatches did in none of these cases have any clinical consequences. Conclusion: By using CaT as a screening method for HC instead of CaI, only two patients with prior unrecognized HC would have been missed and it did not result in a large number of patients with false HC. We therefore find that CaT is an acceptable test when screening for HC in the ED. J Endocrinol Metab. 2021;11(5):108-114 doi: https://doi.org/10.14740/jem757\",\"PeriodicalId\":15712,\"journal\":{\"name\":\"Journal of Endocrinology and Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Endocrinology and Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14740/jem757\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endocrinology and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/jem757","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:与总钙(CaT)测试相比,电离钙(pH=7.4)(CaI)是一项费力的测试。然而,CaI是血液中钙的生物活性部分,因此通常被认为是钙状态的最相关指标。在这项研究中,通过确定未经选择的急诊科(ED)急性入院患者的临床相关高钙血症(HC),比较了CaI和CaT测试。方法:在2018年1月至2019年5月期间,在丹麦一家医院(N=13400)入住急诊室的所有医疗患者中测量CaI和CaT。大多数(97%)患者入院1-3次,总计17838次。作为临床相关HC的限值,CaI使用1.45 mmol/L,CaT使用2.77 mmol/L。不匹配被定义为一个测试等于或高于限值,而另一个测试在其参考区间内或低于其参考区间。在不匹配的情况下,对医疗记录进行审查。结果:17个与CaI不匹配?在16名患者中观察到1.45 mmol/L,其中8名已知患有HC风险疾病。5名患者患有与临床无关的HC,1名患者患有相关性未知的HC,只有2名患者被发现患有先前未知的钙代谢疾病。在接受CaT的患者中观察到三种不匹配?2.77毫摩尔/升。在这些病例中,没有一例出现错配,会产生任何临床后果。结论:使用CaT代替CaI作为HC的筛查方法,只会漏掉两名先前未识别HC的患者,并且不会导致大量的假HC患者。因此,我们发现在ED.J Endocrinol Metab中筛查HC时,CaT是一种可接受的测试。2021年;11(5):108-114 doi:https://doi.org/10.14740/jem757
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Total Calcium and Ionized Calcium (pH = 7.4) Tests Are Equal When Screening Patients for Hypercalcemia at Admission in the Emergency Department: A Retrospective Descriptive Study
Background: Ionized calcium (pH = 7.4) (CaI) is a laborious test compared to tests for total calcium (CaT). However, CaI is the biologically active part of calcium in the blood and is therefore often considered the most relevant measure of calcium status. In this study, CaI and CaT tests were compared by identifying clinically relevant hypercalcemia (HC) in unselected patients acutely admitted to an emergency department (ED). Methods: CaI and CaT were measured in all medical patients admitted to the ED at a single Danish Hospital (N = 13,400) between January 2018 and May 2019. The majority (97%) of the patients were admitted 1 - 3 times summing up to a total of 17,838 admissions. As limits for clinically relevant HC, 1.45 mmol/L for CaI and 2.77 mmol/L for CaT were used. Mismatches were defined as one test being equal to or above the limit while the other test was within or below its reference interval. In cases of mismatch, the medical record was reviewed. Results: Seventeen mismatches with CaI ? 1.45 mmol/L were observed in 16 patients, of whom eight were known with diseases with risk of HC. Five patients had HC with no clinical relevance, one had HC of unknown relevance, and only two patients were discovered as having a prior unknown calcium metabolic disease. Three mismatches were observed in admissions with CaT ? 2.77 mmol/L. Mismatches did in none of these cases have any clinical consequences. Conclusion: By using CaT as a screening method for HC instead of CaI, only two patients with prior unrecognized HC would have been missed and it did not result in a large number of patients with false HC. We therefore find that CaT is an acceptable test when screening for HC in the ED. J Endocrinol Metab. 2021;11(5):108-114 doi: https://doi.org/10.14740/jem757
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Endocrinology and Metabolism
Journal of Endocrinology and Metabolism ENDOCRINOLOGY & METABOLISM-
CiteScore
0.70
自引率
0.00%
发文量
21
期刊最新文献
Acute Effect of COVID-19 Vaccination on Glycemic Profile in Patients With Type 1 Diabetes Mellitus Improvement of Glycemic Control by Metformin Is Associated With Frequency of Defecation Before Treatment in Patients With Type 2 Diabetes Mellitus A Challenging Case of Cushing’s Syndrome Due to Ectopic Adrenocorticotropic Hormone Secretion The Safety of Sodium Glucose Cotransporter 2 Inhibitors for the Elderly Diabetic Patients Triglyceride Glucose-Waist Circumference Is Superior to Other Biochemical Indicators for Diagnosing Prehypertension and Hypertension
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1